Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study

被引：0
|
作者：
Yves Michiels
Olivier Bugnon
Annie Chicoye
Sylvie Dejager
Christine Moisan
François-André Allaert
Catherine Hunault
Laura Romengas
Hubert Méchin
Bruno Vergès
机构：
[1] University of Geneva,Community Pharmacy, School of Pharmaceutical Sciences
[2] University of Lausanne,Department of Endocrinology, Diabetology and Metabolic Diseases
[3] Institut d’Études Politiques de Paris,Department of Diabetology
[4] MSD France,Community Pharmacy, Center for Primary Care and Public Health (Unisanté)
[5] Evaluation Chair BSB-Cenbiotech,undefined
[6] Observia Group,undefined
[7] CHU Dijon,undefined
[8] Pitie Salpetrière,undefined
[9] University of Lausanne,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Disease knowledge; Glucose control; Patient information; Pharmacist; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1291 / 1303
页数：12
相关论文
共 21 条
  • [1] Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study
    Michiels, Yves
    Bugnon, Olivier
    Chicoye, Annie
    Dejager, Sylvie
    Moisan, Christine
    Allaert, Francois-Andre
    Hunault, Catherine
    Romengas, Laura
    Mechin, Hubert
    Verges, Bruno
    ADVANCES IN THERAPY, 2019, 36 (06) : 1291 - 1303
  • [2] Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial
    Maguy Saffouh El Hajj
    Nadir Kheir
    Ahmad Mohd Al Mulla
    Daoud Al-Badriyeh
    Ahmad Al Kaddour
    Ziyad R Mahfoud
    Mohammad Salehi
    Nadia Fanous
    Trials, 16
  • [3] Assessing the effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: study protocol for a randomized controlled trial
    El Hajj, Maguy Saffouh
    Kheir, Nadir
    Al Mulla, Ahmad Mohd
    Al-Badriyeh, Daoud
    Al Kaddour, Ahmad
    Mahfoud, Ziyad R.
    Salehi, Mohammad
    Fanous, Nadia
    TRIALS, 2015, 16
  • [4] Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up
    Peter Bramlage
    Anselm K Gitt
    Steffen Schneider
    Evelin Deeg
    Diethelm Tschöpe
    BMC Cardiovascular Disorders, 14 (1)
  • [5] Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up
    Bramlage, Peter
    Gitt, Anselm K.
    Schneider, Steffen
    Deeg, Evelin
    Tschoepe, Diethelm
    BMC CARDIOVASCULAR DISORDERS, 2014, 14 : 162
  • [6] Reinforced follow-up for children and adolescents with type 1 diabetes and inadequate glycaemic control: a randomized controlled trial intervention via the local pharmacist and telecare
    Gay, CL
    Chapuis, F
    Bendelac, N
    Tixier, F
    Treppoz, S
    Nicolino, M
    DIABETES & METABOLISM, 2006, 32 (02) : 159 - 165
  • [7] Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients: the COMPASS randomized controlled trial
    Takihata, M.
    Nakamura, A.
    Tajima, K.
    Inazumi, T.
    Komatsu, Y.
    Tamura, H.
    Yamazaki, S.
    Kondo, Y.
    Yamada, M.
    Kimura, M.
    Terauchi, Y.
    DIABETES OBESITY & METABOLISM, 2013, 15 (05) : 455 - 462
  • [8] Impact of Pharmacist-Led Diabetes Self-Care Education on Patients With Type 2 Diabetes in Pakistan: A Randomized Controlled Trial
    Bukhsh, Allah
    Khan, Tahir Mehmood
    Phisalprapa, Pochamana
    Duangjai, Acharaporn
    Saokaew, Surasak
    Nawaz, Muhammad Sarfraz
    Ahmed, Hafiz Sajjad
    Goh, Bey-Hing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial
    Breuker, Cyril
    Faucanie, Marie
    Laureau, Marion
    Perier, Damien
    Pinzani, Veronique
    Marin, Gregory
    Sebbane, Mustapha
    Villiet, M.
    TRIALS, 2021, 22 (01)
  • [10] Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial
    Cyril Breuker
    Marie Faucanié
    Marion Laureau
    Damien Perier
    Véronique Pinzani
    Grégory Marin
    Mustapha Sebbane
    M. Villiet
    Trials, 22
123